IMRN
Immuron LimitedNASDAQHealthcare$0.80+2.00%ClosedMarket Cap: $5.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.59
P/S
0.97
EV/EBITDA
0.55
DCF Value
$-527.01
FCF Yield
-64.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
63.7%
Operating Margin
-68.4%
Net Margin
-62.1%
ROE
-43.9%
ROA
-30.7%
ROIC
-29.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $4.1M | 63.4% | $-2.3M | $-1.9M | $-0.27 | — |
| Q4 2025 | $3.3M | 64.0% | $-2.8M | $-2.8M | $-0.47 | — |
| FY 2025 | $7.3M | 65.4% | $-5.3M | $-5.2M | $-0.90 | — |
| Q3 2025 | $1.6M | 64.0% | $-1.4M | $-1.4M | $-0.23 | — |
| Q2 2025 | $4.0M | 66.5% | $-2.5M | $-2.5M | $-0.43 | — |
| Q1 2025 | $2.0M | 66.5% | $-1.3M | $-1.2M | $-0.22 | — |
| Q4 2024 | $2.5M | 69.0% | $-3.8M | $-4.9M | $-0.86 | — |
| FY 2024 | $4.9M | 68.1% | $-5.8M | $-6.9M | $-1.22 | — |
| Q3 2024 | $1.3M | 69.0% | $-1.9M | $-2.4M | $-0.43 | — |
| Q2 2024 | $2.4M | 67.1% | $-2.0M | $-2.1M | $-0.36 | — |
| Q4 2023 | $610.5K | 107.5% | $-816.3K | $-904.1K | $-0.16 | — |
| FY 2023 | $1.8M | 96.4% | $-3.6M | $-3.8M | $-0.66 | — |